High-risk human papillomavirus cervical infection prevalence: a nationwide retrospective study comparing opportunistic and organised screening, France, 2020 to 2023

BACKGROUND In France, cervical cancer screening for females aged 30­–65 years primarily tests for high-risk (HR) human papillomavirus (HPV) infections. AIM We aimed to map the prevalence of cervical infections caused by HPV16 and/or 18, or by any of 12 other carcinogenic HPV genotypes and compare pr...

Full description

Saved in:
Bibliographic Details
Main Author: Samuel Alizon
Format: Article
Language:English
Published: European Centre for Disease Prevention and Control 2025-07-01
Series:Eurosurveillance
Subjects:
Online Access:https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.28.2400689
Tags: Add Tag
No Tags, Be the first to tag this record!